BCG Vaccine: all 109 studies that test it
Page 1 of 2. Open to participants first (17), then studies with results posted, then the rest; newest registration first within each.
- A Study of SHR-1501 Combination With BCG Versus Placebo Combined With BCG in Subjects With Papillary-Only NMIBCRecruitingNCT07726992Phase 3
- A Study of Intravesical FL115 Alone or in Combination With BCG in Non-Muscle Invasive Bladder CancerRecruitingNCT07122414Phase 1/2
- A Tumor Immune Biomarker Guided Approach for Improving Response to BCG in Patients With High-risk NMIBC.Not yet recruitingNCT07064863Phase 1/2
- BCG Revaccination With the Third Dose of Diphtheria-tetanus-pertussis Vaccine and Infant Mortality in AfricaEnrolling by invitationNCT07005726Phase 4
- A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)RecruitingNCT06833073Phase 2
- Clinical Trial of Ablation Therapy in Participants With Intermediate-Risk Non-Muscle Invasive Papillary Bladder CancerNot yet recruitingNCT06829823Phase 2
- Clinical Trial for Evaluating the Efficacy and Safety of BCG for Therapeutic Use in the Prevention of Postoperative Recurrence of Medium/High-risk Non-muscle Invasive Bladder Cancer (NMIBC)RecruitingNCT06241755Phase 3
- A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of SIM0237 Alone or in Combination with BCG in NMIBCRecruitingNCT06186414Phase 1
- A Controlled Human Infection Model (CHIM) With Intradermal BCG in MalawiNot yet recruitingNCT06178666Not applicable
- Antibiotics and Vaccine Immune Responses StudyRecruitingNCT06148025Phase 4
- Does BCG Vaccination Reduce Biomarkers of Alzheimer's Disease?Enrolling by invitationNCT06078891Early Phase 1
- Evaluating the Safety and Immunogenicity of MTBVACRecruitingNCT05947890Phase 2
- Effect of Intravesical B.C.G and Gemcitabine on Semen Quality and Testicular VolumeNot yet recruitingNCT05701332Phase 4
- Safety and Efficacy of Scheduled Intravesical Gemcitabine Versus Intravesical BCG for Intermediate and High Risk Non Muscle Invasive Bladder Cancer: A Prospective, Randomized StudyRecruitingNCT05626101Not applicable
- Evaluating Safety and Efficacy of Verity-BCG in BCG-naïve Patients With Intermediate and High-risk Non-muscle Invasive Bladder (NMIBC)RecruitingNCT05037279Phase 3
- Measles and BCG Vaccines for Mother and ChildRecruitingNCT04899765Phase 4
- Pembrolizumab in Combination With BCG After Ablation in Patients With UUTTCC Without NephroureterectomyNot yet recruitingNCT03345134Phase 2
- A Trial to Evaluate the Effects of BCG in Adults With MCI and Mild-to-Moderate ADCompletedNCT05004688Phase 2Results posted
- Aerosol BCG Challenge Study in Historically BCG-vaccinated VolunteersCompletedNCT04777721Phase 1Results posted
- A Pilot Study of the Effects of BCG Immunization on CSF and Blood-based Biomarkers in Older Adults.CompletedNCT04507126Phase 2Results posted
- BCG Vaccine for Health Care Workers as Defense Against COVID 19CompletedNCT04348370Phase 4Results posted
- A Study of Sasanlimab in People With Non-muscle Invasive Bladder CancerActive, not recruitingNCT04165317Phase 3Results posted
- Avelumab Plus Bacille Calmette-Guerin (BCG) in Patients With Non-muscle Invasive Bladder CancerCompletedNCT03892642Phase 1/2Results posted
- A Study of Nivolumab or Nivolumab Plus Experimental Medication BMS-986205 With or Without Bacillus Calumette-Guerin (BCG) in BCG Unresponsive Bladder Cancer That Has Not Invaded Into the Muscle Wall of the BladderTerminatedNCT03519256Phase 2Results posted
- Safety and Pharmacology Study of Atezolizumab Alone and in Combination With Bacille Calmette-Guérin (BCG) in High-Risk Non-Muscle-Invasive Bladder Cancer (NMIBC) ParticipantsTerminatedNCT02792192Phase 1/2Results posted
- Intravesical BCG Administration to Patients With Invasive Bladder CancerTerminatedNCT02365207Not applicableResults posted
- Evaluate the Response to 2 Induction Courses (12 Intravesical Instillations) of Bacillus Calmette-Guérin (BCG) for High Risk Superficial Bladder CancerCompletedNCT02281383Phase 2Results posted
- Early Versus Delayed BCG Vaccination of HIV-exposed InfantsCompletedNCT02062580Phase 2Results posted
- A Phase 1/2 Study of HS-410 in Patients With Non-Muscle Invasive Bladder Cancer After TURBTTerminatedNCT02010203Phase 1/2Results posted
- Phase I Study of Intralesional Bacillus Calmette-Guerin (BCG) Followed by Ipilimumab in Advanced Metastatic MelanomaTerminatedNCT01838200Phase 1Results posted
- Bacille Calmette Guérin Immunisation at Birth and Childhood Morbidity in Danish Children.CompletedNCT01694108Phase 4Results posted
- Mitomycin C Versus Bacillus Calmette-Guerin in the Intravesical Treatment of Non-Muscle-Invasive Bladder Cancer PatientsTerminatedNCT00974818Phase 3Results posted
- Immunobiology of Diabetes and TuberculosisTerminatedNCT00568854Not applicableResults posted
- ANKTIVA Plus BCG Versus BCG Monotherapy In Participants With BCG-Naïve/BCG-Exposed High-Grade Non-Muscle Invasive Papillary Bladder CancerWithdrawnNCT07551544Phase 3
- Comparison of BCG RIVM and Russian Strains for Treating Non-Muscle-Invasive Bladder Cancer (NMIBC)CompletedNCT06767982Phase 4
- BCG for Therapeutic Use Phase Ⅲ Clinical TrialActive, not recruitingNCT06747455Phase 3
- Clinical Study to Investigate the Safety and Tolerance of Therapeutic BCG in Postoperative Adjuvant Therapy in Subjects With Moderate to High-risk Non-muscular Invasive Bladder Cancer (NMIBC)CompletedNCT06350838Phase 1
- Live Vaccines and Innate Immune Training in COPD.CompletedNCT06257212Phase 4
- BCG Revaccination Study in Diabetic and Non-Diabetic AdultsActive, not recruitingNCT06246851Not applicable
- Disitamab Vedotin Combined With BCG Therapy in HER2-expressing High-risk Non-muscle Invasive Bladder CancerActive, not recruitingNCT06187506Phase 2
- BCG for Therapeutic Use Phase I Clinical TrialCompletedNCT06100653Phase 1
- BCG in Combination With Durvalumab in Adult BCG-naïve, High-risk NMIBC ParticipantsActive, not recruitingNCT05943106Phase 3
- Repeat BCG Vaccinations for the Treatment of New Onset Type 1 Diabetes in Children Age 8-<18 YearsActive, not recruitingNCT05866536Phase 2
- Using BCG Vaccine to Understand Tuberculosis InfectionStatus unknownNCT05820594Not applicable
- Diabetes Diagnosis, Management, Prevention and Education in Guinea-BissauActive, not recruitingNCT05591339Phase 4
- BCG Re-vaccination for Primary Tuberculosis Prophylaxis in the Prison PopulationWithdrawnNCT05541952Phase 4
- Safety and Immunogenicity of VPM1002 Vaccination or BCG Revaccination Against TB in Pre-Adolescents Living With and Without HIV in South AfricaWithdrawnNCT05539989Phase 1/2
- Intravesical BCG vs GEMDOCE in NMIBCActive, not recruitingNCT05538663Phase 3
- The Role of BCG Vaccine in the Clinical Evolution of COVID-19 and in the Efficacy of Anti-SARS-CoV-2 VaccinesActive, not recruitingNCT05507671Phase 3
- BCG Revaccination in Children and AdolescentsSuspendedNCT05330884Phase 3
- Repeat BCG Vaccinations For The Treatment Of Pediatric Type 1 DiabetesActive, not recruitingNCT05180591Phase 2
- Prevention of Acute Respiratory Infection in Taiwanese Institutionalized ElderlyWithdrawnNCT04938323Phase 2/3
- Safety and Efficacy Study of Tislelizumab in Combination With BCG in HR-NMIBC Patients (TACBIN-01)Status unknownNCT04922047Phase 1/2
- Immunological Response of Bladder Cancer Patients Under BCGCompletedNCT04806178Phase 3
- NORTH-REG Dwell-Time StudyActive, not recruitingNCT04701151Phase 4
- Use of BCG Vaccine as a Preventive Measure for COVID-19 in Health Care WorkersActive, not recruitingNCT04659941Phase 2
- BCG Against Covid-19 for Prevention and Amelioration of Severity Trial (BAC to the PAST)WithdrawnNCT04534803Phase 3
- BCG Vaccine in Reducing Morbidity and Mortality in Elderly Individuals in COVID-19 HotspotsCompletedNCT04475302Phase 3
- Prevention, Efficacy and Safety of BCG Vaccine in COVID-19 Among Healthcare WorkersStatus unknownNCT04461379Phase 3
- Immunization With BCG Vaccine to Prevent Tuberculosis InfectionTerminatedNCT04453293Phase 3
- Reducing COVID-19 Related Hospital Admission in Elderly by BCG VaccinationStatus unknownNCT04417335Phase 4
- Bacillus Calmette-guérin Vaccination to Prevent COVID-19CompletedNCT04414267Phase 4
- Efficacy of BCG Vaccination in the Prevention of COVID19 Via the Strengthening of Innate Immunity in Health Care WorkersStatus unknownNCT04384549Phase 3
- COVID-19: BCG As Therapeutic Vaccine, Transmission Limitation, and Immunoglobulin EnhancementCompletedNCT04369794Phase 4
- Reducing Health Care Workers Absenteeism in Covid-19 Pandemic Through BCG VaccineCompletedNCT04328441Phase 3
- BCG Vaccination to Protect Healthcare Workers Against COVID-19CompletedNCT04327206Phase 3
- Bacillus Calmette-Guérin (BCG) and Gemcitabine in People With High-Grade Non-Muscle Invasive Bladder Cancer That Came Back After BCG TreatmentActive, not recruitingNCT04179162Phase 1/2
- Atezolizumab and BCG in High Risk BCG naïve Non-muscle Invasive Bladder Cancer (NMIBC) Patients (BladderGATE)Active, not recruitingNCT04134000Phase 1
- Investigating Immune Responses to Aerosol BCG Challenge in Healthy UK AdultsActive, not recruitingNCT03912207Phase 1
- EMaBS TB Vaccine StudyCompletedNCT03681860Phase 1/2
- Phase II Clinical Trial: Multi-dosing the BCG Vaccine for FibromyalgiaWithdrawnNCT03582085Phase 2
- BCG Vaccination Scar Formation in Children Under Five Years :Factors Affecting Its Formation and Subsequent Adverse Effects .Status unknownNCT03548233Not applicable
- Pembrolizumab (MK-3475) and Bacillus Calmette-Guérin (BCG) as First-Line Treatment for High-Risk T1 Non-Muscle-Invasive Bladder Cancer (NMIBC) and High-Grade Non-Muscle-Invasive Upper Tract Urothelial Carcinoma (NMI-UTUC)]Active, not recruitingNCT03504163Phase 2
- Modern Immunotherapy in BCG-Unresponsive, BCG-Relapsing and High Risk BCG-Naive Non-Muscle Invasive Urothelial Carcinoma of the BladderActive, not recruitingNCT03317158Phase 1/2
- Systems Biology to Identify Biomarkers of Neonatal Vaccine ImmunogenicityCompletedNCT03246230Not applicable
- Biological Samples Obtained by Leukapheresis Induced by Two BCG Vaccinations in BCG-naïve Healthy Adults in the USCompletedNCT03175380Early Phase 1
- QUILT-3.032: A Multicenter Clinical Trial of Intravesical Bacillus Calmette-Guerin (BCG) in Combination With ALT-803 (N-803) in Patients With BCG Unresponsive High Grade Non-Muscle Invasive Bladder CancerActive, not recruitingNCT03022825Phase 2/3
- Testing if BCG (Bacille Calmette-Guérin) Vaccination Can Induce Innate Immune Training in Adult People Above 50 Years of Age in Guinea-BissauCompletedNCT02953327Phase 4
- Clinical Study of Recombinant Mycobacterium Tuberculosis Allergen ESAT6-CFP10 on Healthy People Aged 18-65(III-healthy)CompletedNCT02795260Phase 3
- Influence of BCG on TDaP-IPV VaccinationStatus unknownNCT02771782Phase 4
- Aerosol BCG Challenge Trial in Healthy UK AdultsCompletedNCT02709278Phase 1
- A Trial Investigating the Influence of BCG and Hepatitis B Immunisation at Birth on Neonatal Immune Responses: The Early Life Vaccines and Immunity StudyCompletedNCT02444611Not applicable
- Leukapheresis Sampling for Immune Responses After BCG Vaccination in BCG-naïve Healthy Adults in the USCompletedNCT02413502Early Phase 1
- Phase IIb Clinical Study of Recombinant Mycobacterium Tuberculosis Allergen ESAT6-CFP10 on Healthy People Aged 18-65CompletedNCT02389322Phase 2
- PRIME: Pilot Study Evaluating Percutaneous Vaccination of BCG for Bladder CancerCompletedNCT02326168Early Phase 1
- Role of BCG as Booster VaccinationCompletedNCT02175420Not applicable
- A Study of Intravesical BCG in Combination With ALT-803 in Patients With Non-Muscle Invasive Bladder CancerActive, not recruitingNCT02138734Phase 1/2
- Effects of BCG on Influenza Induced Immune ResponseCompletedNCT02114255Phase 2/3
- A Clinical Challenge Study of BCG in Healthy VolunteersCompletedNCT02088892Not applicable
- Effects of BCG on Immune ResponseCompletedNCT02085590Phase 2/3
- Repeat BCG Vaccinations for the Treatment of Established Type 1 DiabetesActive, not recruitingNCT02081326Phase 2
- A Randomized Trial of Providing BCG Vaccination ImmediatelyTerminatedNCT01989026Phase 4
- Melbourne Infant Study - Bacille Calmette Guérin (BCG) for Allergy & Infection ReductionCompletedNCT01906853Phase 3
- Phase II/III Clinical Study CSF470 Plus BCG Plus GM-CSF vs IFN Alpha 2b in Stage IIB, IIC and III Melanoma PatientsStatus unknownNCT01729663Phase 2/3
- The Impact of Intravesical Gemcitabine and 1/3 Dose Bacillus Calmette-Guerin on the Quality of Life in Superficial Bladder CancerCompletedNCT01697306Phase 2
- BCG Modulation of the recMAGE-A3 + AS15 ASCI Response in the Treatment of Non Muscle Invasive Bladder Cancer (NMIBC) PatientsCompletedNCT01498172Phase 1
- Study of AERAS 422 in Healthy AdultsCompletedNCT01340820Phase 1
- Study of the Safety and Immunogenicity of Bacille Calmette Guerin (BCG) VaccineCompletedNCT00654316Phase 1
- A Study to Quantify Bacille Calmette Guerin (BCG) and Characterise the Immune Response After BCG VaccinationCompletedNCT00653627Phase 1
- Determination of Dosing and Frequency of BCG Administration to Alter T-Lymphocyte Profiles in Type I DiabeticsCompletedNCT00607230Phase 1